ORCL logoORCL
Oracle Corp.

40,354
Loading...
Loading...
News
all
press releases
Previewing Q3 Earnings: What Can Investors Expect?
We have regularly flagged in recent weeks that the Q3 estimate revisions trend has been positive since late April, reversing the prior course. But what else is there to know about the upcoming Q3 cycle?
Zacks·2d ago
News Placeholder
More News
News Placeholder
AMD Shares Ride on Strong EPYC Demand: Buy, Sell or Hold the Stock?
AMD's EPYC and Instinct momentum drives cloud, AI and enterprise growth, but valuation concerns and NVIDIA rivalry weigh on the outlook.
Zacks·2d ago
News Placeholder
Oracle's NetSuite Momentum: Can It Boost Cloud Growth to New Heights?
ORCL's NetSuite ERP drives double-digit SaaS growth, boosting cloud revenue momentum and positioning the company for stronger long-term demand.
Zacks·2d ago
News Placeholder
Oracle (ORCL) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Get a deeper insight into the potential performance of Oracle (ORCL) for the quarter ended August 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
Zacks·2d ago
News Placeholder
Oracle Cuts Over 200 Jobs In California As Earnings Release Nears — Stock Edges Up Premarket
Oracle CEO Safra Catz was among the invitees to the lunch hosted by Trump for tech and business leaders at the White House on Thursday.
Stocktwits·2d ago
News Placeholder
Oracle Stock Before Q1 Earnings: Buy Now or Wait for Results?
ORCL's cloud momentum and AI innovations show promise, but investors may wait for clearer visibility on partnership revenue synergies before buying the stock.
Zacks·3d ago
News Placeholder
Ciena (CIEN) Tops Q3 Earnings and Revenue Estimates
Ciena (CIEN) delivered earnings and revenue surprises of +28.85% and +4.00%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3d ago
News Placeholder
Beat the Market the Zacks Way: Oracle, Intellia, Pharming Group in Focus
Even in a choppy market, Zacks' strategies are spotlighting winners like Oracle, Intellia, and Pharming Group, proving the value of a disciplined, research-driven approach.
Zacks·5d ago
News Placeholder
Oracle (ORCL) to Report Q1 Results: Wall Street Expects Earnings Growth
Oracle (ORCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·6d ago
News Placeholder
The Zacks Analyst Blog Highlights Lilly, Oracle, Procter & Gamble and Comstock Holding Companies
Zacks spotlights Eli Lilly, Oracle, Procter & Gamble, and microcap Comstock Holding, with pharma and staples facing pressure while Oracle and Comstock show momentum.
Zacks·9d ago

Latest ORCL News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.